Patients should follow the exact instructions provided by their PlexusDx care team and should not change dose, timing, or route without provider guidance
retatrutide remains investigational What changes the decision Timing after escalation, symptom severity, hydration, other medicines, and red-flag symptoms Sources: Retatrutide phase 2 obesity trial Key Takeaway See your GLP-1 options in about 2 minutes
In reality, healthcare providers evaluate much more than BMI alone
All of these can be helpful but do not replace the medication your healthcare provider ordered for you
Being precise about those four brand names is the single most useful thing a Californian can do before starting a telehealth intake
Whats Happening Eli Lilly filed lawsuits on March 26 in federal courts (New Jersey and Delaware), alleging that Empower and Strive are producing unauthorized, potentially unsafe versions of tirzepatide